Call to Schedule Free Consultation at Over 80 Centers Worldwide!

Premature ovarian failure (POF)

Cerebral Palsy

Autism spectrum disorder (ASD)

Intravenous Mesenchymal

Stem Cells and Covid Vaccine Paper

Diabetic kidney disease (DKD)

Our Publications

Diabetic Kidney Failure

 Autism Spectrum Disorder

Premature Ovarian Failure

Stem Cell and COVID

Premature Ovarian Failure

Intranasal Stem Cell Therapy

Wharton’s Jelly Properties 

Brand Ambassador Gallery

Free webinar with R3 Stem Cell presented by CEO David Greene, MD, PhD, MBA, discussing stem cell therapy

Free Webinar with R3 Stem Cell

All You Need to Know About Stem Cell Therapy Presented by CEO David Greene, MD, PhD, MBA!

Success Stories

The USA Stem Cell Leader Offers Procedures In 8 Countries Including

Call to schedule your free consultation at over 80 centers worldwide!

Disclaimer

Stem cell therapy is considered experimental and is regulated by the U.S. Food and Drug Administration (FDA), but it is not FDA-approved. R3 Stem Cell does not offer stem cell therapy as a cure for any medical condition. No statements made on this site have been evaluated or approved by the FDA. This site does not provide medical advice. All content is for informational purposes only and is not a substitute for professional medical consultation, diagnosis, or treatment. Reliance on any information provided by R3 Stem Cell, its employees, others appearing on this website at the invitation of R3 Stem Cell, or other visitors to the website is solely at your own risk. R3 Stem Cell does not recommend or endorse any specific tests, products, procedures, opinions, or other information that may be mentioned on this website. R3 Stem Cell is not responsible for the outcome of your procedure. The FDA considers stem cell therapy experimental at this point.

 

Copyright © 2017-2026 R3 Stem Cell. All Rights Reserved.